Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma

  • STATUS
    Recruiting
  • End date
    Aug 31, 2022
  • participants needed
    100
  • sponsor
    Centre Hospitalier Universitaire, Amiens
Updated on 31 July 2021
brimonidine tartrate ophthalmic solution
treatment of glaucoma

Summary

Open-angle glaucoma is a degeneration of the optic nerve, highlighted by campimetric alterations, and wose only current therapeutic target is the lowering of the intra-ocular pressure (using eye drops, surgery or laser). MEMOPTIC is a tablet combining citicoline, magnesium and Gingko biloba, which have a neuroprotective effect already used in neurodegenerative diseases such as Alzheimer's disease for example. Citicoline has also shown several promising results in ophthalmological diseases (glaucoma, amblyopia or more recently in ischemic optic neuropathies). The citicoline used in eye drops (NEURODROP) has already shown results on the preservation of the vision of glaucomatous patients.

The purpose of this project is to determine if MEMOPTIC can have an effect, in addition to the conventional treatments, in the preservation of vision of patients treated for an open-angle glaucoma.

Details
Condition Glaucoma, Pigmentary glaucoma, Visual field
Treatment MEMOPTIC, usual treatment of glaucoma
Clinical Study IdentifierNCT04499157
SponsorCentre Hospitalier Universitaire, Amiens
Last Modified on31 July 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

diagnosis of GCAO defined by OCT RNFL alterations and visual fields defects
age between 20 and 80 years old
Well controled intra-ocular pressure under treatment (PIO<21mmHg or decreased by 20% compared to initial the PIO)

Exclusion Criteria

retinal or macular disease
diagnosis of cataract or surgery of cataract during the follow-up
allergy to citicolin
ocular hypertonia due to a secondary cause (like corticosteroids)
history of anterior, intermediate or posterior uveitis
general treatment affecting PIO (beta blockers, corticosteroids)
pregnancy or breastfeeding
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note